This study is designed to speed up approval of safer, more effective drugs to treat patients diagnosed with acute myeloid leukemia (AML).
The objective of this study is to change the treatment paradigm for patients with acute myeloid leukemia (AML) by improving AML treatments and accelerating their approval.
What is AML?
What is Beat AML
LLS's Leadership Role